Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADiTx Therapeutics, Inc. | 470 | reported | 08 Nov 2023 | tx 10+31,970−10,000 |
| PACE HEALTH MANAGEMENT SYSTEMS INC | 0 | reported | 29 Aug 2012 | tx 5+60,000−50,000 |
| Altimmune, Inc. | 0 | reported | 20 Jan 2017 | tx 26+357,850−160,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Nov 2023 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 470 | 0.00 USD | deriv |
| 29 Sept 2021 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 11,500 | 0.00 USD | deriv |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 1,600 | 2.93 USD | first after silence |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 700 | 2.94 USD | |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 3,000 | 2.94 USD | |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 2,000 | 2.93 USD | |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 700 | 2.94 USD | |
| 01 Jun 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 2,000 | 2.93 USD | |
| 13 Oct 2020 | OTHER | ADiTx Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 20 Jan 2017 | EXERCISE | Altimmune, Inc. | 20,000 | 3.11 USD | |
| 20 Jan 2017 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 28 Nov 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 2.20 USD | |
| 28 Nov 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 1.69 USD | |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 1.35 USD | |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 1.51 USD | |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 1.64 USD | |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 1.45 USD | |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 1.60 USD | |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Sept 2016 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 01 Jun 2021.